arrow
O

Oriol Pich

the francis crick institute
H指数:52
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genetic background sets the trajectory of experimental cancer evolution

遗传背景决定了实验性癌症进化的轨迹

Nature
IF48.5
2026-07-220
OAAI
Subclonal immune evasion in non-small cell lung cancer

非小细胞肺癌中的亚克隆免疫逃逸

2026-05-180
OAAI
Evolutionary characterization of lung cancer metastasis

肺癌转移的进化表征

Nature
IF48.5
2026-04-290
OAAI
Retraction Note: Antibodies against endogenous retroviruses promote lung cancer immunotherapy

撤稿注意: 针对内源性逆转录病毒的抗体促进肺癌免疫治疗

Nature
IF48.5
2026-01-140
OAAI
Somatic evolution following cancer treatment in normal tissue

正常组织中癌症治疗后的体细胞进化

Nature
IF48.5
2025-12-100
OA
Subclonal immune evasion in non-small cell lung cancer

非小细胞肺癌中的亚克隆免疫逃逸

2025-07-030
OAAI
The mutagenic forces shaping the genomes of lung cancer in never smokers

在从不吸烟者中塑造肺癌基因组的诱变力

Nature
IF48.5
2025-07-020
PRE
Origins and impact of extrachromosomal DNA
Nature
IF48.5
2024-11-060
OAAI
MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution

MHC Hammer揭示了癌症进化中的遗传和非遗传HLA破坏

2024-10-020
OAAI
Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models

基因组内异质性在多区域非小细胞肺癌患者来源的异种移植模型中的表现

2024-05-314
OAAI
Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer

骨髓和T细胞的空间结构协调肺癌的免疫逃避和临床结果

2024-04-1211
OAAI
Pervasive HLA disruption fuels cancer evolution
2024-03-220
PRE
The origins and clinical impact of extrachromosomal DNA across 39 cancers
2024-03-220
PRE
The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinoma

基于人工智能的模型ANORAK改善肺腺癌的组织病理学分级

2024-01-102
OAAI
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance
2023-12-0419
OAAI
Mutational signature dynamics shaping the evolution of oesophageal adenocarcinoma

影响食管腺癌演变的突变特征动力学

2023-07-159
OAAI